Vaccination coverage of children with rheumatic diseases compared with healthy controls: a retrospective case-control study

References

• Lindsley CB, Guillermo Russo RA. Managing Children with Rheumatic Diseases. In: Petty R, Laxer R, and Lindsley C, et al, editors. Textbook of Pedia Rheum. 7th ed. Philadelphia: Elsevier; 2016. p. 129–139e3. doi:10.1016/B978-0-323-24145-8.00011-9.
   Google Scholar
• Swart J, Giancane G, Horneff G, et al. Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from pharmachild and national registries. Arthritis Res Ther. 2018;20(1):1–11. doi: 10.1186/s13075-018-1780-z
   PubMedGoogle Scholar
• Esposito S, Prada E, Lelii M, et al. Immunization of children with secondary immunodeficiency. Human Vaccines Immunother. 2015;11(11):2564–2570. doi: 10.1080/21645515.2015.1039208
   PubMed Web of Science ®Google Scholar
• Beukelman T, Xie F, Baddley JW, et al. Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis. Arthritis & Rheumatism. 2013;65(5):1384–1389. doi: 10.1002/art.37866
   PubMed Web of Science ®Google Scholar
• Higgins GCJPC. Complications of treatments for pediatric rheumatic diseases. Pediatr Clin North Am. 2018;65(4):827–854. doi: 10.1016/j.pcl.2018.04.008
   PubMed Web of Science ®Google Scholar
• Becker I, Horneff G. research. Risk of serious infection in juvenile idiopathic arthritis patients associated with tumor necrosis factor inhibitors and disease activity in the German biologics in pediatric rheumatology registry. Arthritis Care Res. 2017;69(4):552–560. doi: 10.1002/acr.22961
   PubMed Web of Science ®Google Scholar
• Glück T, Müller-Ladner UJCID. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clinl Infect Dis. 2008;46(9):1459–1465. doi: 10.1086/587063
   PubMed Web of Science ®Google Scholar
• Bloom DE, Canning D, Weston M. The value of vaccination. In: Stevens P, editor. Fighting the diseases of poverty. New York: Routledge; 2008. p. 214–238.
   Google Scholar
• Rémy V, Zöllner Y, Heckmann U, et al. Vaccination: the cornerstone of an efficient healthcare system. J Mark Access Health Policy. 2015;3(1):27041. doi: 10.3402/jmahp.v3.27041
   PubMedGoogle Scholar
• Morin M-P, Quach C, Fortin E, et al. Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centre. Rheumatology. 2012;51(11):2046–2050. doi: 10.1093/rheumatology/kes175
   PubMed Web of Science ®Google Scholar
• Minden K, Niewerth M, Borte M, et al. Immunization in children and adolescents with rheumatic diseases. Zeitschrift für Rheumatologie. 2007;66(2):111–2, 114. doi: 10.1007/s00393-007-0150-z
   PubMed Web of Science ®Google Scholar
• Eskiocak M, Marangoz B. Türkiye’de Bağışıklama Hizmetlerinin Durumu. 2018 [cited 2022 Dec 15]. Available from: file:///C:/Users/drozl/Downloads/Documents/turkiyede_bagisiklama_hizmetlerinin_durumu.pdf
   Google Scholar
• Uziel Y, Moshe V, Onozo B, et al. Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: multicenter, retrospective data collection. Vaccine. 2020;38(9):2198–2201. doi: 10.1016/j.vaccine.2020.01.037
   PubMed Web of Science ®Google Scholar
• Çakmak F, Akgün Ö, Demirkan FG, et al. Live attenuated measles, mumps and rubella booster vaccine in children diagnosed with rheumatic disease: a single-center study. Eur J Pediatr. 2022;182(1):135–140. doi: 10.1007/s00431-022-04646-x
   PubMed Web of Science ®Google Scholar
• Jansen MH, Rondaan C, Legger GE, et al. EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Ann Rheumatic Dis. 2022;82(1):35–47. doi: 10.1136/annrheumdis-2022-222574
   PubMed Web of Science ®Google Scholar
• Rollet-Cohen V, Mirete J, Dingulu G, et al. Suboptimal vaccination coverage of recommended vaccines among French children with recurrent autoinflammatory fever syndromes: a study from the juvenile inflammatory rheumatism cohort. Clin Rheumatol. 2021;40(7):2855–2864. doi: 10.1007/s10067-020-05553-y
   PubMed Web of Science ®Google Scholar
• Balažiová B, Kuková Z, Mišíková D, et al. Real-life vaccination coverage in Slovak children with rheumatic diseases. Front Pediatr. 2022;10:10. doi: 10.3389/fped.2022.956136
   Web of Science ®Google Scholar
• Welzel T, Kuemmerle-Deschner J, Sluka C, et al. Vaccination completeness in children with rheumatic diseases: a longitudinal, observational multicenter cohort study in Switzerland. Front Pediatr. 2022;10:1481. doi: 10.3389/fped.2022.993811
   Web of Science ®Google Scholar
• 2022 ECfDPaCE. Vaccine schedules in all countries in the EU/EEA. 2022 [cited 2022 Jun 12]. Available from: https://vaccine-schedule.ecdc.europa.eu/
   Google Scholar
• Kostik MM, Lubimova NA, Fridman IV, et al. The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary centre study. Pediatr Rheumatol. 2021;19(1):1–10. doi: 10.1186/s12969-021-00594-2
   PubMedGoogle Scholar
• Ozen S, Kuemmerle‐Deschner JB, Cimaz R, et al. International retrospective chart review of treatment patterns in severe familial Mediterranean fever, tumor necrosis factor receptor–associated periodic syndrome, and mevalonate kinase deficiency/hyperimmunoglobulinemia D syndrome. Arthritis Care Res. 2017;69(4):578–586. doi: 10.1002/acr.23120
   Web of Science ®Google Scholar
• Bizjak M, Blazina Š, Markelj G, et al. Vaccination coverage in children with rheumatic diseases. Clin Exp Rheumatol. 2019;38(1):164–170.
   PubMed Web of Science ®Google Scholar
• Lima Melo JM, Pileggi GC, Martins De CarvalhoL, et al. Immunization status of children with rheumatic diseases: can the pediatric rheumatologist help to improve? (abstract) pediatric rheumatology In European society congress. 2010.
   Google Scholar
• Chehab G, Richter JG, Brinks R, et al. Vaccination coverage in systemic lupus erythematosus—a cross-sectional analysis of the German long-term study (LuLa cohort). Rheumatology. 2018;57(8):1439–1447. doi: 10.1093/rheumatology/key120
   PubMed Web of Science ®Google Scholar